Female infertility

ASK4SAM Launches New York Camp Lejeune Toxic Water Legal Injury Claims Hotline

Retrieved on: 
Friday, September 9, 2022

Silberstein, Awad, and Miklos, P.C. (ASK4SAM) has recently sponsored a toll free hotline number for New York residents who have been affected by the Camp Lejeune Toxic Water Contamination and who want to speak with an attorney at no cost about their potential claim.

Key Points: 
  • (ASK4SAM) has launched a Camp Lejeune Toxic Water Injury Claims Hotline to help residents of New York State seek compensation for themselves or their loved ones if they stationed at Camp Lejeune and were harmed by the toxic water that plagued the Marine Corps Base Camp Lejeune in Jacksonville, NC, which is in Eastern North Carolina during the qualified span of time discussed below.
  • Residents of New York State can call this number and speak to an attorney about whether they have a claim in the recently decided Camp Lejeune contaminated water supply case.
  • For New York Residents or their loved ones who were stationed at Camp Lejeune for a period of 30 days or longer are elligible to call the New York State Camp Lejeune Toxic Water Injury Claims Hotline , by calling 888-6-LEJEUNE, or by visiting ask4sam.net and clicking on the Camp Lejeune Claims option on the main page, or clicking the link in the description below to learn more about this civil claim about the contaminated drinking water on the base.
  • They have multiple office locations across New York City, and they set up the Camp Lejeune Toxic Water Injury Claim Hotline to help further streamline the fair compensation and disability benefits for those exposed to toxic materials on the military base.

Global Female Infertility Drug Pipeline Market Report 2022: Insights about 12 Pipelines Drugs Including Emerging Drugs - OXO-001 (Oxolife) & Nolasiban (ObsEva) - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 25, 2022

The "Global Female Infertility - Pipeline Insight, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Female Infertility - Pipeline Insight, 2022" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This "Female Infertility - Pipeline Insight, 2022" report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Female Infertility pipeline landscape.
  • A detailed picture of the Female Infertility pipeline landscape is provided which includes the disease overview and Female Infertility treatment guidelines.
  • The assessment part of the report embraces, in depth Female Infertility commercial assessment and clinical assessment of the pipeline products under development.

Europe Female Infertility Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 6, 2022

The "Europe Female Infertility Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Female Infertility Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The latest research Europe Female Infertility Market and Competitive Landscape - 2021, provides comprehensive insights into Female Infertility pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Female Infertility treatment options, Female Infertility late-stage clinical trials pipeline, Female Infertility prevalence by countries, Female Infertility market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Female Infertility pipeline: Find out drugs in clinical trials for the treatment of Female Infertility by development phase 3, phase 2, by pharmacological class and company
    Female Infertility drugs: Identify key drugs marketed and prescribed for Female Infertility in the US, including trade name, molecule name, and company
    Female Infertility market valuations: Find out the market size for Female Infertility drugs in 2020 by countries.

Female Infertility Treatment Drugs Market by Therapy, Route of Administration, Distribution Channel, and Region - Global Size, Share, Outlook, and Opportunity Analysis, 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 27, 2021

The "Female Infertility Treatment Drugs Market, by Therapy, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Female Infertility Treatment Drugs Market, by Therapy, by Route of Administration, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Market players are focusing on various growth strategies such as agreements, partnerships, and collaborations to accelerate the development of drugs for infertility treatment, which is expected to boost growth of the global female infertility treatment drugs market over the forecast period.
  • For instance, in January 2020, Bayer AG announced the expansion of their partnership with Evotec SE, a biotechnology company focusing on women health, with a new five-year, multi-target collaboration to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (PCOS), which is one of the causes of infertility in females.
  • Moreover, in January 2019, Ferring Pharmaceuticals, a biopharmaceutical company entered into an exclusive agreement with Sun Pharmaceutical Industries Ltd., an India-based multinational pharmaceutical company to acquire the U.S. commercialization rights for a generic version of Ganirelix Acetate injection which is used for treatment of female infertility.

United States Female Infertility Market and Competitive Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 23, 2021

The "US Female Infertility Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Female Infertility Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • US Female Infertility Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Female Infertility pipeline products, Female Infertility epidemiology, Female Infertility market valuations and forecast, Female Infertility drugs sales and competitive landscape in the US.
  • Female Infertility pipeline: Find out the products in clinical trials for the treatment of Female Infertility by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Female Infertility drugs: Identify key products marketed and prescribed for Female Infertility in the US, including trade name, molecule name, and company
    Female Infertility market valuations: Find out the market size for Female Infertility drugs in 2019 in the US.
  • Find out how the market advanced from 2017 and forecast to 2026
    Female Infertility drugs market share: Find out the market shares for key Female Infertility drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Female Infertility products

Creative Medical Technology Holdings Identifies Cellular Mechanism of Patented OvaStem® Female Infertility/Ovarian Failure Treatment

Retrieved on: 
Wednesday, February 10, 2021

PHOENIX, Feb. 10, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings announced today new data explaining mechanisms of action of its patented OvaStem female infertility/ovarian failure treatment.

Key Points: 
  • PHOENIX, Feb. 10, 2021 /PRNewswire/ --(OTC-CELZ) Creative Medical Technology Holdings announced today new data explaining mechanisms of action of its patented OvaStem female infertility/ovarian failure treatment.
  • These cells are a type of immune cell which the Company has previously patented for regeneration of lumbar discs (US Patent #10,842,815).
  • "Cellular therapy is making significant advances in the treatment of cancer, degenerative diseases, and autoimmunity."
  • See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov .

2020 Europe Female Infertility Market & Competitive Landscape - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 29, 2020

The "Europe Female Infertility Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Female Infertility Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • The research report Europe Female Infertility Market and Competitive Landscape - 2020, provides comprehensive insights into the Female Infertility pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following: Female Infertility treatment options, Female Infertility late stage clinical trials pipeline, Female Infertility prevalence by countries, Female Infertility market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Female Infertility pipeline: Find out drugs in clinical trials for the treatment of Female Infertility by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Female Infertility drugs: Identify key drugs marketed and prescribed for Female Infertility in the US, including trade name, molecule name, and company
    Female Infertility market valuations: Find out the market size for Female Infertility drugs in 2019 by countries.

A Vista Partners Interview with Steve Shum CEO of INVO Bioscience Regarding Increasing Access to Care for Fertility Treatment

Retrieved on: 
Friday, June 19, 2020

We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility.

Key Points: 
  • We are a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility.
  • The INVO Procedure is a revolutionaryin vivomethod of vaginal incubation that offers patients a more natural and intimate experience.
  • Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART).
  • Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care.

Boston IVF Study Shows Infertility is a Top Stressor Despite COVID-19 Pandemic

Retrieved on: 
Monday, June 8, 2020

The study, published in the journal Reproductive Biomedicine online, comprised a survey of over 2,200 female infertility patients.

Key Points: 
  • The study, published in the journal Reproductive Biomedicine online, comprised a survey of over 2,200 female infertility patients.
  • The authors report that prior to the pandemic, women experiencing infertility ranked infertility as their top stressor, followed by their job, and then money.
  • At the beginning of the pandemic in the Boston area, the top stressor was infertility, followed by their job, and then the Coronavirus.
  • During the surge, the top stressor remained infertility, followed by the Coronavirus and then their job.

2020 Female Infertility Market, Pipeline, Epidemiology, Competitive Analysis, Drug Sales and Shares

Retrieved on: 
Wednesday, May 13, 2020

DUBLIN, May 12, 2020 /PRNewswire/ -- The "Global Female Infertility Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 12, 2020 /PRNewswire/ -- The "Global Female Infertility Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • This research report provides comprehensive insights into the Female Infertility pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • The research analyzes and forecasts the Female Infertility market size and drug sales.
  • Female Infertility pipeline: Find out drugs in clinical trials for the treatment of Female Infertility by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Female Infertility drugs: Identify key drugs marketed and prescribed for Female Infertility in the US, including trade name, molecule name, and company
    Female Infertility market valuations: Find out the market size for Female Infertility drugs in 2019 by countries.